OurChild: A Health IT Solution to Reduce Minority Health Disparities

Sponsor
NYU Langone Health (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04677647
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD) (NIH)
264
1
1
13
20.3

Study Details

Study Description

Brief Summary

Chinese American immigrant families are a fast-growing immigrant group with unmet early childhood mental health needs. The team proposes to design, build, and implement OurChild, an integrated mHealth/EHR solution to increase access to early childhood mental health knowledge and mental health services and resources for Chinese American children ages 2-6 years old and their parents in the Sunset Park Brooklyn.

Condition or Disease Intervention/Treatment Phase
  • Other: OurChild mHealth Digital Platform
N/A

Detailed Description

The goal of this study is to reduce health disparities by designing a digital solution (OurChild) that facilitates connection and bidirectional exchange of information across the cultural, contextual, language, and setting differences that are key barriers to early childhood mental health knowledge and care access for the Chinese American community in Sunset Park, Brooklyn. The first study aim is to iteratively design, build, and test OurChild. To do this, the team will 1) collaborate with family, clinical, and community stakeholders to conduct an early childhood mental health context/needs analysis and participatory design and discovery activities; 2) build a digital library of early childhood mental health resources accessible from OurChild; and 3) pilot and assess the usability and acceptability of a beta version of OurChild in a mixed-methods, cross-sectional cohort of 12 Chinese American parents and their 2- to 6-year-old children (N=24) who receive care at the Sunset Park 7th Avenue Family Health Center; and 5) optimize the design, features, and performance to create OurChild 1.0. The second study aim is to evaluate the reach, effectiveness, adoption, implementation and maintenance of OurChild 1.0 through an implementation cohort study with 120 parent/child dyads (N=240). A mixed-methods approach using metadata collected with the OurChild app, parent-reported data from the app, EHR data, and post-implementation key informant interviews with providers and other stakeholders to determine whether use of OurChild increases referrals of young children for a mental health consultation or evaluation (Primary Aim) will be used. The secondary aims include examining whether use of OurChild increases 1) parent self-efficacy; 2) parent-provider engagement; and 3) linkage with community early childhood resources.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
264 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
OurChild: A Health IT Solution to Reduce Minority Health Disparities
Anticipated Study Start Date :
Oct 31, 2022
Anticipated Primary Completion Date :
Sep 30, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: OurChild

Other: OurChild mHealth Digital Platform
The intervention being created and tested in this study is OurChild an integrated mHealth/EHR app, initially designed for the Chinese American community in Sunset Park, Brooklyn. All participants will be assigned to either beta versions undergoing development, or to version 1.0.

Outcome Measures

Primary Outcome Measures

  1. Change in Number of Referrals [Month 18, Month 45]

    Change in number of referrals to NYU Langone Child Psychiatry or Developmental Pediatrics

Secondary Outcome Measures

  1. Change in Score on Parental Self-Efficacy Scale [Month 25, Month 45]

    The General Self-Efficacy Scale is a 10-item psychometric scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life.

  2. Change in Amount of parent-provider engagement [Month 18, Month 45]

    Engagement defined as at least one interaction or messaging exchange between parent and provider through OurChild messaging portal

  3. Change in accessing resources on App [Month 25, Month 45]

    Access to clinical and community early childhood and family services and resources; access defined as click through on resources library tab in OurChild app

  4. Score on Betz Physician Confidence Scale [Month 48]

    The Betz Scale is a collection of 11 statements describing the provider's perceived barriers to the identification and management of child mental health issues. Responses to each statement consist of Strongly Agree (0), Agree, Uncertain, Disagree, and Strongly Disagree (5). The total range of score is 0-55, with a higher score indicating higher physician confidence in assessing and treating mental health disorders.

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Child must be 24 to 72 months old

  • Child must have been receiving pediatric primary care at the 7th Ave FHC for at least 6 months

  • Child must be identified as Chinese and/or preferred language is Chinese in EHR

  • Parents must be at least 18 years old

  • Parents must be the child's parent/legal guardian

  • Parents must be able and willing to provide informed consent

Exclusion Criteria:
  • Siblings and parents of previously enrolled children

  • Parents who do not have access to an iOS or Android smartphone

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYU Langone Health New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health
  • National Institute on Minority Health and Health Disparities (NIMHD)

Investigators

  • Principal Investigator: Simona Kwon, DrPH, NYU Langone Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT04677647
Other Study ID Numbers:
  • 20-01468
First Posted:
Dec 21, 2020
Last Update Posted:
Aug 9, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by NYU Langone Health

Study Results

No Results Posted as of Aug 9, 2022